A fraction of the pro alpha 1(I) and pro alpha 2(I) chains in type I procollagen synthesized by the fibroblasts from a proband with a lethal variant of osteogenesis imperfecta were overmodified by posttranslational reactions. After digestion with pepsin, some of the alpha 1(I) chains were recovered as disulfide-linked dimers. Mapping of cyanogen bromide peptides indicated that the disulfide link was contained in alpha 1-CB6, the cyanogen bromide fragment containing amino acid residues 823-1014 of the alpha 1(I) chain. Nucleotide sequencing of cDNA clones demonstrated a substitution of T for G that converted glycine 904 of the alpha 1(I) chain to cysteine. A large fraction of the type I procollagen synthesized by the proband's fibroblasts had a thermostability that was 3-4 degrees C lower than the normal type I procollagen as assayed by brief proteinase digestion. In addition, the type I procollagen synthesized by the proband's fibroblasts was secreted with an abnormal kinetic pattern in that there was a lag period of about 30 min in pulse-chase experiments. The mutation of glycine to cysteine was not found in type I procollagen synthesized by fibroblasts from the proband's parents. Therefore, the mutation was a sporadic one. However, the mother's fibroblasts synthesized a type I procollagen in which part of the pro alpha chains were overmodified and had a lower thermostability. Therefore, the proband may have inherited a mutated allele for type I procollagen from her mother that contributed to the lethal phenotype. The mother was asymptomatic. She was somewhat short and had slightly blue sclerae but no definitive signs of a connective tissue abnormality. The observations on the mother indicated, therefore, that a mutation that causes synthesis of a type I procollagen with a lowered thermal stability does not necessarily produce a heritable disorder of connective tissue.
C D Constantinou, K B Nielsen, D J Prockop
Title and authors | Publication | Year |
---|---|---|
A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome
C Odiatis, I Savva, M Pieri, P Ioannou, P Petrou, G Papagregoriou, K Antoniadou, N Makrides, C Stefanou, DG Ljubanović, G Nikolaou, DB Borza, K Stylianou, O Gross, C Deltas |
2021 | |
Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies
O Gross, L Perin, C Deltas |
Nephrology Dialysis Transplantation | 2014 |
Autosomal Recessive Osteogenesis Imperfecta: A Puzzle for Bone Formation, Structure and Function
SP Boudko, EN Pokidysheva, HP Bächinger |
Current Genetic Medicine Reports | 2013 |
Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8
H Kaneko, H Kitoh, T Matsuura, A Masuda, M Ito, M Mottes, F Rauch, N Ishiguro, K Ohno |
Human Genetics | 2011 |
Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood
F Malfait, S Symoens, JD Backer, T Hermanns-Lê, N Sakalihasan, CM Lapière, P Coucke, AD Paepe |
Human Mutation | 2007 |
Role of Adult Mesenchymal Stem Cells in Bone Tissue Engineering Applications: Current Status and Future Prospects
JR Mauney, V Volloch, DL Kaplan |
Tissue Engineering | 2005 |
High Proportion of Mutant Osteoblasts Is Compatible with Normal Skeletal Function in Mosaic Carriers of Osteogenesis Imperfecta* *Presented as a platform presentation at the National Meeting of the American Society of Bone and Mineral Research (Late-Breaking Research Session), San Antonio, TX, September 2002
WA Cabral, JC Marini |
The American Journal of Human Genetics | 2004 |
Osteogenesis Imperfecta
F Antoniazzi, M Mottes, P Fraschini, PC Brunelli, L Tat?? |
Paediatric Drugs | 2000 |
Osteogenesis imperfecta calls for caution-first letter
JC Marini |
Nature Medicine | 1999 |
Osteogenesis imperfecta calls for caution-second letter
NJ Bishop |
Nature Medicine | 1999 |
Reply to osteogenesis imperfecta calls for caution
EM Horwitz, DJ Prockop, LA Fitzpatrick, WW Koo, JC Marx, MK Brenner |
Nature Medicine | 1999 |
Osteogenesis Imperfecta, Rehabilitation Medicine, Fundamental Research and Mesenchymal Stem Cells
AI Caplan |
Connective Tissue Research | 1995 |
Tissue-specific Expression of the Gene for Type I Procollagen (COL1A1) in Transgenic Mice: ONLY 476 BASE PAIRS OF THE PROMOTER ARE REQUIRED IF COLLAGEN GENES ARE USED AS REPORTERS
BP Sokolov, L Ala-Kokko, R Dhulipala, M Arita, JS Khillan, DJ Prockop |
The Journal of biological chemistry | 1995 |
Molecular Genetic Techniques for Prenatal Diagnosis
K SUZUMORI, M TANEMURA, R ADACHI |
Congenital Anomalies | 1994 |
Self-assembly of collagen I from a proband homozygous for a mutation that substituted serine for glycine at position 661 in the alpha 2(I) chain. Possible relationship between the effects of mutations on critical concentration and the severity of the phenotype
AM Romanic, LD Spotila, E Adachi, J Engel, Y Hojima, DJ Prockop |
The Journal of biological chemistry | 1994 |
Osteogenesis imprefecta and type-I collagen mutations. A lethal variant caused by a Gly910Ala substitution in the alpha1(I) chain
M VALLI, A SANGALLI, A ROSSI, M MOTTES, A FORLINO, R TENNI, PF PIGNATTI, G CETTA |
European Journal of Biochemistry | 1993 |
Somatic cell mosaicism: Another source of phenotypic heterogeneity in nuclear families with osteogenesis imperfecta
CD Constantinou-Deltas, RL Ladda, DJ Prockop |
American Journal of Medical Genetics | 1993 |
A Cysteine for Glycine Substitution at Position 175 in an α1 (I) Chain of Type I Collagen Produces A Clinically Heterogeneous Form of Osteogenesis Imperfecta
MK Wirtz, VH Rao, RW Glanville, ME Labhard, PJ Pretorius, WN de Vries, WJ de Wet, DW Hollister |
Connective Tissue Research | 1993 |
Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring
DM Milewicz, AM Witz, AC Smith, DK Manchester, G Waldstein, PH Byers |
The American Journal of Human Genetics | 1993 |
Deletion of 19 base pairs in intron 13 of the gene for the pro?2(I) chain of type-I procollagen (COL1A2) causes exon skipping in a proband with type-I osteogenesis imperfecta
J Zhuang, G Tromp, H Kuivaniemi, K Nakayasu, DJ Prockop |
Human Genetics | 1993 |
An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen
JR Shapiro, ML Stover, VE Burn, MB McKinstry, AL Burshell, SD Chipman, DW Rowe |
Journal of Clinical Investigation | 1992 |
Expression of mutant α(I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV
SD Chipman, JR Shapiro, MB McKinstry, ML Stover, P Branson, DW Rowe |
Journal of Bone and Mineral Research | 1992 |
Molecular nosology of heritable disorders of connective tissue
P Beighton, AD Paepe, JG Hall, DW Hollister, FM Pope, RE Pyeritz, B Steinmann, P Tsipouras |
American Journal of Medical Genetics | 1992 |
Lethal perinatal osteogenesis imperfecta due to a type I collagen α2(I) gly to arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch
JF Bateman, I Moeller, M Hannagan, D Chan, WG Cole |
Human Mutation | 1992 |
Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients
M Mörike, RE Brenner, GB Bushart, WM Teller, U Vetter |
Biochemical Journal | 1992 |
Comparative study on the thermostability of collagen I of skin and bone: Influence of posttranslational hydroxylation of prolyl and lysyl residues
H Notbohm, S Mosler, M Bodo, C Yang, H Lehmann, B Btge, PK Mller |
Journal of Protein Chemistry | 1992 |
The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagen
WG Cole, E Patterson, J Bonadio, PE Campbell, DW Fortune |
Journal of medical genetics | 1992 |
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine ?1(I) 901 substitution in a type-I collagen gene
M Mottes, A Sangalli, M Valli, MG Lira, R Tenni, P Buttitta, PF Pignatti, G Cetta |
Human Genetics | 1992 |
Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production
PK Mays, RJ McAnulty, JS Campa, GJ Laurent |
Biochemical Journal | 1991 |
Osteogenesis imperfecta: translation of mutation to phenotype
PH Byers, GA Wallis, MC Willing |
Journal of medical genetics | 1991 |
Substitution of cysteine for glycine at residue 415 of one allele of the alpha 1(I) chain of type I procollagen in type III/IV osteogenesis imperfecta
AC Nicholls, J Oliver, DV Renouf, M Keston, FM Pope |
Journal of medical genetics | 1991 |
A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain
M Valli, M Mottes, R Tenni, A Sangalli, MG Lira, A Rossi, F Antoniazzi, G Cetta, PF Pignatti |
The Journal of biological chemistry | 1991 |
The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix
RJ Wenstrup, AW Shrago-Howe, LW Lever, CL Phillips, PH Byers, DH Cohn |
The Journal of biological chemistry | 1991 |
A 9-base pair deletion in COL1A1 in a lethal variant of osteogenesis imperfecta
JR Hawkins, A Superti-Furga, B Steinmann, R Dalgleish |
The Journal of biological chemistry | 1991 |
Dominant mutations in familial lethal and severe osteogenesis imperfecta
L Cohen-Solal, J Bonaventure, P Maroteaux |
Human Genetics | 1991 |
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta
R Tenni, P Biglino, K Dyne, A Rossi, M Filocamo, F Pendola, P Brunelli, P Buttitta, C Borrone, G Cetta |
Journal of Inherited Metabolic Disease | 1991 |
A Substitution of Cysteine for Glycine 904 in COL1A1 in a Proband with Lethal Osteogenesis Imperfecta and in Her Asymptomatic Mother
CD Constantinou, MA Pack, SB Young, DJ Prockop |
Annals of the New York Academy of Sciences | 1990 |
Brittle bones - fragile molecules: disorders of collagen gene structure and expression
PH Byers |
Trends in Genetics | 1990 |
Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta
RJ Wenstrup, MC Willing, BJ Starman, PH Byers |
The American Journal of Human Genetics | 1990 |
Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent
GA Wallis, BJ Starman, AB Zinn, PH Byers |
The American Journal of Human Genetics | 1990 |
Phenotypic heterogeneity in osteogenesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1)
CD Constantinou, M Pack, SB Young, DJ Prockop |
The American Journal of Human Genetics | 1990 |
The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues
WG Cole, PE Campbell, JG Rogers, JF Bateman |
Journal of medical genetics | 1990 |
Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybrids
DK Grange, GS Gottesman, MB Lewis, JC Marini |
Nucleic Acids Research | 1990 |
Anomalous Cysteine in Type I Collagen. Localisation by Chemical Cleavage of the Protein Using 2-Nitro-5-Thiocyanobenzoic Acid and by Mismatch Analysis of cDNA Heteroduplexes
R Tenni, A Rossi, M Valli, M Mottes, PF Pignatti, G Cetta |
Matrix | 1990 |
Bone and Mineral Research
A Perault-Staub, J Staub, G Milhaud |
Bone and Mineral Research | 1990 |
Extracellular Matrix Genes
LJ Sandell, CD Boyd |
Extracellular Matrix Genes | 1990 |
Connective Tissue Diseases in the Skin: From Molecules to Symptoms
T Krieg, M Aumailley |
The Journal of Dermatology | 1990 |
Clinical Screening for Collagen Defects in Connective Tissue Diseases
DH Cohn, PH Byers |
Clinics in Perinatology | 1990 |
Advances in Human Genetics
H Harris, K Hirschhorn |
1990 | |
The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen
WG Cole, CW Chow, JG Rogers, JF Bateman |
Journal of medical genetics | 1990 |
Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype
BJ Starman, D Eyre, H Charbonneau, M Harrylock, MA Weis, L Weiss, JM Graham, PH Byers |
Journal of Clinical Investigation | 1989 |
Prenatal diagnosis and prevention of inherited abnormalities of collagen
FM Pope, SC Daw, P Narcisi, AR Richards, AC Nicholls |
Journal of Inherited Metabolic Disease | 1989 |
Inherited disorders of collagen gene structure and expression
PH Byers |
American Journal of Medical Genetics | 1989 |
Type I procollagen: The gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue
DJ Prockop, CD Constantinou, KE Dombrowski, Y Hojima, KE Kadler, H Kuivaniemi, G Tromp, BE Vogel |
American Journal of Medical Genetics | 1989 |
Osteogenesis imperfecta type IV
JC Marini, DK Grange, GS Gottesman, MB Lewis, DA Koeplin |
The Journal of biological chemistry | 1989 |
Substitution of Serine for α1(I)-Glycine 844 in a Severe Variant of Osteogenesis Imperfecta Minimally Destabilizes the Triple Helix of Type I Procollagen
M Pack, CD Constantinou, K Kalia, KB Nielsen, DJ Prockop |
The Journal of biological chemistry | 1989 |
A Single Base Mutation That Substitutes Serine for Glycine 790 of the α 1 (III) Chain of Type III Procollagen Exposes an Arginine and Causes Ehlers-Danlos Syndrome IV
G Tromp, H Kuivaniemi, H Shikata, DJ Prockop |
The Journal of biological chemistry | 1989 |